Olson M M, Ilada P B, Apelgren K N
Department of Surgery, Michigan State University, 1200 E. Michigan Avenue, East Lansing, MI 48912, USA.
Surg Endosc. 2003 Aug;17(8):1322. doi: 10.1007/s00464-002-4546-1. Epub 2003 Jun 13.
Portal vein thrombosis (PVT) is a complication of hepatic disease and a potentially lethal complication of splenectomy. The reported incidence of this complication is low (approximately 1%). However, its true incidence may have been underestimated due to difficulty in making the diagnosis. Herein we report the case of a 19 year-old woman who presented with a 2-year history of idiopathic thrombocytopenic purpura (ITP). Because she had become refractory to medical therapy, she underwent laparoscopic splenectomy. She was discharged on postoperative day 2 after an uncomplicated procedure. She did well, complaining only of mild backache, until postoperative day 21, when she presented with nausea, vomiting, and leukocytosis. CT showed PVT and superior mesenteric vein thrombosis. Despite heparin and fluid administration, her condition worsened. At laparotomy, she had diffuse small bowel edema and congestion. At a second-look procedure 24 h later, nearly all her jejunum and ileum were necrotic. After three procedures, she was left with 45 cm of proximal and 10 cm of distal small bowel. Bowel continuity was restored 8 weeks later. She continued on warfarin anticoagulation therapy for 1 year. Postsplenectomy PVT is most often seen following splenectomy for myeloproliferative disorders and almost never after trauma. The large splenic vein stump and the hypercoagulable state in patients with splenomegaly are thought to be contributory. The presentation of PVT is vague, without defining signs or symptoms. Color-flow Doppler and contrast-enhanced CT scans are the best methods for the nonoperative diagnosis of PVT. Aggressive thrombolysis offers the best hope for clot lysis and maintenance of bowel viability. Even vague symptoms must be considered seriously following splenectomy.
门静脉血栓形成(PVT)是肝脏疾病的一种并发症,也是脾切除术的一种潜在致命并发症。该并发症的报告发病率较低(约1%)。然而,由于诊断困难,其实际发病率可能被低估了。在此,我们报告一例19岁女性患者,她有2年特发性血小板减少性紫癜(ITP)病史。由于对药物治疗无效,她接受了腹腔镜脾切除术。手术过程顺利,术后第2天出院。术后她恢复良好,仅诉有轻度背痛,直到术后第21天,她出现恶心、呕吐和白细胞增多。CT显示门静脉血栓形成和肠系膜上静脉血栓形成。尽管给予了肝素和补液治疗,她的病情仍恶化。剖腹探查时,她有弥漫性小肠水肿和充血。24小时后再次手术时,几乎所有空肠和回肠都坏死了。经过三次手术后,她仅剩下近端45厘米和远端10厘米的小肠。8周后恢复了肠道连续性。她继续接受华法林抗凝治疗1年。脾切除术后门静脉血栓形成最常见于因骨髓增殖性疾病行脾切除术之后,而在创伤后几乎从未发生。脾静脉大残端和脾肿大患者的高凝状态被认为是促成因素。门静脉血栓形成的表现不明确,没有明确的体征或症状。彩色多普勒血流成像和增强CT扫描是门静脉血栓形成非手术诊断的最佳方法。积极的溶栓治疗为血栓溶解和维持肠道活力提供了最大希望。脾切除术后即使是模糊的症状也必须认真考虑。